Product NDC: | 0019-N452 |
Proprietary Name: | SODIUM IODIDE I 131 |
Non Proprietary Name: | sodium iodide i 131 |
Active Ingredient(s): | 1 mCi/mL & nbsp; sodium iodide i 131 |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, GELATIN COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0019-N452 |
Labeler Name: | Mallinckrodt Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA016517 |
Marketing Category: | NDA |
Start Marketing Date: | 20120125 |
Package NDC: | 0019-N452-F6 |
Package Description: | 1 CAPSULE in 1 CAN (0019-N452-F6) > 5 mL in 1 CAPSULE |
NDC Code | 0019-N452-F6 |
Proprietary Name | SODIUM IODIDE I 131 |
Package Description | 1 CAPSULE in 1 CAN (0019-N452-F6) > 5 mL in 1 CAPSULE |
Product NDC | 0019-N452 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sodium iodide i 131 |
Dosage Form Name | CAPSULE, GELATIN COATED |
Route Name | ORAL |
Start Marketing Date | 20120125 |
Marketing Category Name | NDA |
Labeler Name | Mallinckrodt Inc. |
Substance Name | SODIUM IODIDE I-131 |
Strength Number | 1 |
Strength Unit | mCi/mL |
Pharmaceutical Classes | Radioactive Therapeutic Agent [EPC],Radiopharmaceutical Activity [MoA] |